Clinical Trial Update: A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral Leishmaniasis [Phase 2]

View source ↗

Summary

Phase II multicentre randomized blinded study to evaluate the efficacy and safety of two LXE408 regimens for primary visceral leishmaniasis; currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• LXE408 (LXE408)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Primary Visceral Leishmaniasis | Phase 2 | Status: ACTIVE_NOT_RECRUITING